Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Snyder

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
The Journal of Gene Medicine|March 30, 2000
Selective uptake and sustained expression of AAV vectors following subcutaneous deliveryB A Donahue, J G McArthur, S K Spratt, et al.
Science Translational Medicine|May 18, 2012
Gene therapy for aromatic L-amino acid decarboxylase deficiencyWuh-Liang Hwu, Shin-ichi Muramatsu, Sheng-Hong Tseng, et al.
The Journal of Gene Medicine|November 13, 2004
Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectorsDeborah Farson, Thomas C Harding, Lucy Tao, et al.
Nature Biotechnology|August 14, 1998
Regulation of gene expression in vivo following transduction by two separate rAAV vectorsK G Rendahl, S E Leff, G R Otten, et al.
Methods (San Diego, Calif.)|November 5, 2002
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectorsSergei Zolotukhin, Mark Potter, Irene Zolotukhin, et al.
Nature Genetics|July 1, 1997
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsR O Snyder, C H Miao, G A Patijn, et al.
Human Gene Therapy|November 23, 2006
Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adultsMark L Brantly, L Terry Spencer, Margaret Humphries, et al.
Nature Medicine|January 12, 1999
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectorsR O Snyder, C Miao, L Meuse, et al.
Gene Therapy|January 23, 2004
Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunityY C Zhang, M Powers, C Wasserfall, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal MuscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
The Journal of Gene Medicine|March 30, 2000
Selective uptake and sustained expression of AAV vectors following subcutaneous deliveryB A Donahue, J G McArthur, S K Spratt, et al.
Science Translational Medicine|May 18, 2012
Gene therapy for aromatic L-amino acid decarboxylase deficiencyWuh-Liang Hwu, Shin-ichi Muramatsu, Sheng-Hong Tseng, et al.
The Journal of Gene Medicine|November 13, 2004
Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectorsDeborah Farson, Thomas C Harding, Lucy Tao, et al.
Nature Biotechnology|August 14, 1998
Regulation of gene expression in vivo following transduction by two separate rAAV vectorsK G Rendahl, S E Leff, G R Otten, et al.
Methods (San Diego, Calif.)|November 5, 2002
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectorsSergei Zolotukhin, Mark Potter, Irene Zolotukhin, et al.
Nature Genetics|July 1, 1997
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsR O Snyder, C H Miao, G A Patijn, et al.
Human Gene Therapy|November 23, 2006
Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adultsMark L Brantly, L Terry Spencer, Margaret Humphries, et al.
Nature Medicine|January 12, 1999
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectorsR O Snyder, C Miao, L Meuse, et al.
Gene Therapy|January 23, 2004
Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunityY C Zhang, M Powers, C Wasserfall, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal MuscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Pageof 12